Logo Valence
Populaire
Se connecter
Loading data for CERS — first visit, this takes a few seconds.

Ajouter à la liste de suivi

n/a

: CERS · Prix en temps réel · USD
n/a
n/a (n/a)
À la clôture : Invalid Date

(CERS) Stock Price, Analysis & Data

Aucune donnée disponible

Cours acheteurn/a
Capitalisation boursièren/a
Chiffre d’affaires (ttm)n/a
Résultat net (ttm)n/a
Bêtan/a
EPS (ttm)n/a
Ratio P/E (ttm)n/a
P/E prévisionneln/a
P/B (ttm)n/a
P/S (ttm)n/a
Earnings DateNov 6, 2025
Cours vendeurn/a
VolumeNaN
Volume moy. (20D)n/a
Ouverturen/a
Clôture précédenten/a
Fourchette du journ/a - n/a
Intervalle de 52 semainesn/a - n/a
Analysten/a
Objectif de prixn/a
Dividendesn/a
Date ex-dividenden/a

À propos de CERS

A detailed description of the company is not yet available....

[En savoir plus]
Industrie n/a
Secteur n/a
Date d’introduction n/a
Employés n/a
Bourse n/a
Symbole boursier CERS
Profil complet de l’entreprise

Surprise sur les résultats

a publié ses résultats trimestriels le Jul 30, 2026 :
  • Chiffre d’affaires de $57.44M est inférieur aux estimations de $0, avec 9.53% croissance en glissement annuel.
  • EPS de -0.01 est inférieur aux estimations de 0.00, avec 75.00% croissance en glissement annuel.

    • Prochaine publication des résultats

    devrait publier ses résultats le Nov 6, 2025, après la fermeture du marché.
    Les analystes prévoient un chiffre d’affaires de ... Passer à l’offre supérieure
    news image

    2 semaines il y a · MarketBeat

    Cerus Q2 Earnings Call Highlights

    Cerus (NASDAQ:CERS) reported second-quarter product revenue growth of 10% year over year and raised the low end of its 2026 product revenue outlook, citing demand for its INTERCEPT blood-safety produc...

    news image

    2 mois il y a · Insider Monkey

    Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M

    Cerus Corporation (NASDAQ:CERS) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 8, Cerus Corporation (NASDAQ:CERS) closed a new debt facility with MidCap Financial, providin...

    news image

    2 mois il y a · Zacks

    Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?

    Here is how BrightSpring Health Services, Inc. (BTSG) and Cerus (CERS) have performed compared to their sector so far this year.

    news image

    2 mois il y a · Insider Monkey

    Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG

    Cerus Corporation (NASDAQ:CERS) is one of the best oversold growth stocks to invest in now. BTIG upgraded Cerus Corporation (NASDAQ:CERS) to Buy from Neutral on May 1, reiterating a $4 price target. T...

    news image

    3 mois il y a · Simply Wall St.

    3 Penny Stocks With Market Caps Under $500M And Promising Growth

    Over the last 7 days, the United States market has dropped by 1.0%, but it remains up 23% over the past year, with earnings forecasted to grow by 17% annually. In such a dynamic landscape, identifying...

    Page 1 de 2